Lung Cancer Vaccine

Lung Cancer Vaccine Trial Continues

The cancer vaccine program is enrolling a second cohort of subjects to study the effects of the vaccine in lung cancer patients. The vaccine is delivered.

Harvard Gazette: Lung cancer vaccine under development

Medical investigators have begun to see some light at the end of a long tunnel that may lead to a vaccine against lung cancer.

BBC NEWS | Health | Lung cancer vaccine to be tested

A large-scale trial to test a vaccine against the most common form of lung cancer is launched.

Promising Lung Cancer Vaccine, Study: Some Patients Have No

Three patients injected with GVAX had no recurrence of lung cancer for more than three years. The experimental vaccine also slowed the spread in others in a.

PENN Medicine News: University of Pennsylvania Health System in

The lung cancer vaccine, developed by AVAX Technologies, is based on vaccine technology that has been shown promising results in patients with metastatic.

Biomira's Phase 2 Lung Cancer Vaccine Trial Shows No Safety Concerns

Biomira Inc announced the interim results of a phase 2 non-small cell lung cancer (NSCLC) single-arm, multi-centre, open label study of BLP25 Liposome.

Lung Cancer Vaccine Enters Large-scale Clinical Trial

A new treatment for the most common form of lung cancer, developed from initial research by Cancer Research UK scientists, has entered a pivotal phase III.

Newsobserver.com | Lung cancer vaccine to be tested locally

UNC-Chapel Hill is participating in a study that will test a treatment vaccine for lung cancer. UNC-CH is not yet recruiting patients but expects to start.

Lung Cancer Vaccine (GVAX) - Clinical Stage Portfolio

Lung Cancer Vaccine (GVAX)developed by Cell Genesys.

Consumer Health News, Information and Resources Updated Daily

Lung Cancer Vaccine Sunlight Helps Put Lung Cancer in the Shade Blood Test to Detect Lung Cancer Being Eyed. •, PET Scans Could Boost Lung Cancer.